Induction of Potent Humoral and Cell-Mediated Immune Responses Following Direct Injection of DNA Encoding the HIV Type 1envandrevGene Products
- 1 August 1995
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 11 (8), 933-943
- https://doi.org/10.1089/aid.1995.11.933
Abstract
DNA vaccines have the potential of giving rise to a potent cell-mediated immune response by inducing intracellular synthesis and subsequent antigenic presentation of encoded antigens. We have tested a DNA vaccine specific for human immunodeficiency virus type 1 (HIV-1) by the injection of animals with expression plasmids encoding the HIV-1 envelope protein and the Rev regulatory protein. Injection of both plasmids into mice, rabbits, or macaques was found to induce high levels of specific antibodies capable of efficiently inhibiting both HIV-1 infection and envelope-mediated cell fusion. A readily detectable delayed-type hypersensitivity (DTH) response was demonstrable in injected mice and lymphocytes derived from these mice proliferated in response to an HIV-1 envelope V3 loop-specific peptide. Interestingly, the injected mice or macaques also developed a strong cytotoxic T lymphocyte (CTL) response against target cells pulsed with the V3 peptide. Taken together, these data demonstrate that injection of HIV-1 gene expression plasmids can induce potent humoral and cell-mediated immune responses and suggest that DNA vaccines may prove to be significantly beneficial as a means of immunizing against HIV-1.Keywords
This publication has 51 references indexed in Scilit:
- Semiquantitative, Nonradioactive RT-PCR Detection of Immunoglobulin mRNA in Human B Cells and Plasma CellsDNA and Cell Biology, 1994
- A Strategy for Prophylactic Vaccination Against HIVScience, 1993
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.The Journal of Experimental Medicine, 1992
- Galactose Oxidation in the Design of Immunogenic VaccinesScience, 1992
- Cell-Mediated Immune Response to Human Immunodeficiency Virus (HIV) Type 1 in Seronegative Homosexual Men with Recent Sexual Exposure to HIV-1The Journal of Infectious Diseases, 1992
- Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1-infected individualsAIDS, 1991
- Immune response and epitope mapping of a candidate hiv‐1 p17 vaccine hgp30Journal of Clinical Laboratory Analysis, 1990
- Trans-activation of human immunodeficiency virus occurs via a bimodal mechanismCell, 1986
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985